Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Rapid-Onset Immune Thrombocytopenia Following Alemtuzumab Treatment in Relapsing, Remitting Multiple Sclerosis
Multiple Sclerosis
(-)
074
Authors/Disclosures
Mark Obermann, MD, FÂ鶹´«Ã½Ó³»­ (Department of Neurology, Klinikum Weser-Egge)
PRESENTER 		No disclosure on file